Stock Events

Stock Events

enGene Therapeutics (ENGN) Q4 2024 Earnings

19DecConfirmed

Q1 2024

Q2 2024

Q3 2024

Q4 2024

-0.46

-0.39

-0.33

-0.26

Details

Expected EPS

-0.395714

Actual EPS

-0.35

Surprise EPS

0.05

Surprise Percent

+11.55%

Description

enGene Therapeutics (ENGN) has reported earnings of -0.35 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.